Harvard Bioscience Updates Financial Calendar
Harvard Bioscience published an update to its financial calendar.
Related stories
Monro reports second-quarter loss per share
M impact | EQUITY | Oct 29, 2026, 11:43 AM UTC
FTI Consulting Reports Third-Quarter Revenue of $1.01 Billion
FTI Consulting reported third-quarter revenue of $1.01 billion.
M impact | EQUITY | Oct 29, 2026, 11:40 AM UTC
Belden Reports $11.4M Third-Quarter Loss
M impact | EQUITY | Oct 29, 2026, 11:36 AM UTC
Belden Reports Third-Quarter Revenue of $966 Million
M impact | EQUITY | Oct 29, 2026, 11:30 AM UTC
Cheniere Reports Q3 Results, Raises 2026 Guidance and Dividend
Cheniere reported third-quarter 2026 financial results, raised its full-year 2026 financial guidance and increased its quarterly dividend by over 12%.
M impact | EQUITY | Oct 29, 2026, 11:30 AM UTC
Monro Reports Second-Quarter Fiscal 2027 Financial Results
Sales decreased 1.8% in the quarter ended September 26, 2026.
M impact | EQUITY | Oct 29, 2026, 11:30 AM UTC